Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in graves' disease

Thyroid

Volumn 21, Issue 12, 2011, Pages 1295-1299

  Kamijo, Keiichi ^a   Murayama, Hiroshi ^b   Uzu, Takahiro ^b   Togashi, Kazuyoshi ^b   Olivo, Paul D ^c   Kahaly, George J ^d  

^a Kamijo Thyroid Research Institute   (Japan)

^b YAMASA CORPORATION   (Japan)

^c Quidel Corporation   (United States)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYCLIC AMP; MONOCLONAL ANTIBODY; THIAMAZOLE; THYROID BLOCKING AUTOANTIBODY; THYROTROPIN; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; THYROTROPIN RECEPTOR AUTOANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; AUTOIMMUNE PAINLESS THYROIDITIS; AUTOIMMUNE THYROIDITIS; BINDING ASSAY; BINDING INHIBITION ASSAY; BIOASSAY; BIOREPORTER ASSAY; CHO CELL; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; GRAVES DISEASE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

EID: 82955165733     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0056     Document Type: Review

References (15)

1. Brent GA 2008 Graves' disease. N Engl J Med 358:2594-2605. (Pubitemid 351831360)
2. Schott M, Hermsen D, Broecker-Preuss M, Casati M, Mas JC, Eckstein A, Gassner D, Golla R, Graeber C, Helden JV, Inomata K, Jarausch J, Kratzsch J, Miyazaki N, Moreno MAN, Murakami T, Roth HJ, Stock W, Noh JY, Scherbaum WA, Mann K, 2009 Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease (GD): an international multicentre trial. Clin Endocrinol 71:566-573.
3. Lytton SD, Li Y, Olivo PD, Kohn LD, Kahaly GJ 2010 Novel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid stimulating immunoglobulins. Clin Expl Immunol 162:438-446.
4. Lytton SD, Kahaly GJ 2010. Bioassay for TSH-receptor autoantibodies: an update. Autoimmun Rev 10:116-122.
5. Kamijo K, Murayama H, Uzu T, Togashi K, Kahaly GJ 2010A novel bioreporter assay for TSH receptor antibodies using a chimeric TSH Receptor (Mc4) is more useful in differentiation of Graves' Disease from painless thyroiditis compared with conventional TSAb assay using porcinethyroid cells. Thyroid 20:851-856.
6. Sanders, J, Jeffreys J, Depraetere H, Evans M, Richards T, Kiddie A, Brereton K, Premawardhana LDKE, Chirgadze DY, Nü ńez Miguel R, Blundell TL, Furmaniak J, Rees Smith B 2004 Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function. Thyroid 14:560-570. (Pubitemid 39097076)
7. Vos XG, Smit N, Endert E, Tijssen JG, Wiersinga WH 2008 Frequency and Characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study. Clin Endocrinol (Oxf) 69:311-317. (Pubitemid 352009024)
8. Kamijo K 2010 Study on cutoff values for differential diagnosis between Graves' disease and painless thyroiditis using the TRAb (Elecsys TRAb) measurement via the fully automated electrochemiluminescense immunoassay system Endocrine J 57:895-902.
9. Tahara K, Ban T, Minegishi T, Kohn LD 1991 Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients. Biochem Biophys Res Commun 179:70-77.
10. Kamijo K, Togashi K 2011 ECLIA-TRAb and Mc4-TSAb. J Jap Thyroid Association 2:106-110.
11. Takeda K, Takamatsu J, Kasagi K, Sakane S, Ikegami Y, Isotani H, Majima T, Kitaoka H, Iida Y, Ikekubo K, Konishi J, Mozai T 1988 Development of hyperthyroidism following primary hypothyroidism: a case report with changes in thyroid-related antibodies. Clin Endocrinol (Oxf) 28: 341-344.
12. Kasuga Y, Sugenoya A, Kobayashi S, Shimizu T, Onuma H, Shingu K, Asanuma K, Hama Y, Iida F 1993 Development of hypothyroidism with thyroid stimulation blocking in a patient with hyperthyroid Graves' disease: a case report. Endocrine J 40:227-230. (Pubitemid 23257677)
13. Lytton SD, Ponto KA, Kanitz M, Matheis N, Kohn LD Kahaly GJ 2010A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy J Clin Endocrinol Metab 95:2123-2131.
14. Ponto KA, Kanitz M, Olivo PD, Pitz S, Pfeiffer N, Kahaly GJ 2011 Clinical relevance of thyroid stimulating immunoglobulins in Graves' ophthalmopathy. Ophthalmology 118: 2279-2285.
15. Grass YZ, Kin MR, Faiman C, Kohn LD, Tahara K, Gupta MK 1999 Epitope heterogeneity of thyrotropin receptorblocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptor. Thyroid 9: 531-537. (Pubitemid 29296114)